Martin Shkreli Tells Wall Street Journal Drug Price Hikes, Over-The-Top Persona Reasons Behind His Arrest

By: via Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) confirmed in a press release Monday that Martin Shkreli will no longer continue serving ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.